← 返回首页
美国 · 股市与财经 · The Motley Fool

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

来源:The Motley Fool · 美国 10 小时前

Wall Street is quite bullish on BioNTech. In fact, among the 20 analysts covering it, 13 rate the stock a strong buy, while the remainder rate it a hold. Their target prices imply…

在 The Motley Fool 阅读全文 登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.fool.com)

推荐阅读